1. Atluri N, Joksimovic SM, Oklopcic A, Milanovic D, Klawitter J, Eggan P, Krishnan K, Covey DF, Todorovic SM, Jevtovic-Todorovic V. (2018) A neurosteroid analogue with T-type calcium channel blocking properties is an effective hypnotic, but is not harmful to neonatal rat brain.
Br J Anaesth, 120 (4): 768-778.
[PMID:29576117]
2. Chemin J, Monteil A, Dubel S, Nargeot J, Lory P. (2001) The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells.
Eur J Neurosci, 14 (10): 1678-86.
[PMID:11860462]
3. Chemin J, Monteil A, Perez-Reyes E, Bourinet E, Nargeot J, Lory P. (2002) Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.
J Physiol (Lond.), 540 (Pt 1): 3-14.
[PMID:11927664]
4. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide.
EMBO J, 20 (24): 7033-40.
[PMID:11742980]
5. Choe W, Messinger RB, Leach E, Eckle VS, Obradovic A, Salajegheh R, Jevtovic-Todorovic V, Todorovic SM. (2011) TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Mol Pharmacol, 80 (5): 900-10.
[PMID:21821734]
6. Francois A, Kerckhove N, Meleine M, Alloui A, Barrere C, Gelot A, Uebele VN, Renger JJ, Eschalier A, Ardid D et al.. (2013) State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Pain, 154 (2): 283-93.
[PMID:23257507]
7. Ghaleb YE, Schneeberger PE, Polstra AM, van Hagen JM, Campiglio M, Denecke J, Fernandez-Quintero M, Liedl KR, Kutsche K, Flucher BE. (2020) Two CaV3.3 (CACNA1I) Gain-of-Function Mutations Linked to Epilepsy and Intellectual Disability Affect Gating Properties and the Window Current.
Biophysical Journal, 118: 106a.
DOI: 10.1016/j.bpj.2019.11.732
8. Giordanetto F, Knerr L, Wållberg A. (2011) T-type calcium channels inhibitors: a patent review.
Expert Opin Ther Pat, 21 (1): 85-101.
[PMID:21087200]
9. Gomora JC, Daud AN, Weiergräber M, Perez-Reyes E. (2001) Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.
Mol Pharmacol, 60 (5): 1121-32.
[PMID:11641441]
10. Gomora JC, Murbartián J, Arias JM, Lee JH, Perez-Reyes E. (2002) Cloning and expression of the human T-type channel Ca(v)3.3: insights into prepulse facilitation.
Biophys J, 83 (1): 229-41.
[PMID:12080115]
11. Heady TN, Gomora JC, Macdonald TL, Perez-Reyes E. (2001) Molecular pharmacology of T-type Ca2+ channels.
Jpn J Pharmacol, 85 (4): 339-50.
[PMID:11388636]
12. Huguenard JR, Gutnick MJ, Prince DA. (1993) Transient Ca2+ currents in neurons isolated from rat lateral habenula.
J Neurophysiol, 70 (1): 158-66.
[PMID:8395572]
13. Jarvis MF, Scott VE, McGaraughty S, Chu KL, Xu J, Niforatos W, Milicic I, Joshi S, Zhang Q, Xia Z. (2014) A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Biochem Pharmacol, 89 (4): 536-44.
[PMID:24726441]
14. Klassen T, Davis C, Goldman A, Burgess D, Chen T, Wheeler D, McPherson J, Bourquin T, Lewis L, Villasana D et al.. (2011) Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.
Cell, 145 (7): 1036-48.
[PMID:21703448]
15. Kozlov AS, McKenna F, Lee JH, Cribbs LL, Perez-Reyes E, Feltz A, Lambert RC. (1999) Distinct kinetics of cloned T-type Ca2 + channels lead to differential Ca2 + entry and frequency-dependence during mock action potentials.
Eur J Neurosci, 11 (12): 4149-58.
[PMID:10594640]
16. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klöckner U, Schneider T, Perez-Reyes E. (1999) Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family.
J Neurosci, 19 (6): 1912-21.
[PMID:10066244]
17. Lee JH, Gomora JC, Cribbs LL, Perez-Reyes E. (1999) Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.
Biophys J, 77 (6): 3034-42.
[PMID:10585925]
18. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ et al.. (2007) Genome-wide atlas of gene expression in the adult mouse brain.
Nature, 445 (7124): 168-76.
[PMID:17151600]
19. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA. (2000) Mibefradil block of cloned T-type calcium channels.
J Pharmacol Exp Ther, 295 (1): 302-8.
[PMID:10991994]
20. McGivern JG. (2006) Pharmacology and drug discovery for T-type calcium channels.
CNS Neurol Disord Drug Targets, 5 (6): 587-603.
[PMID:17168744]
21. McKay BE, McRory JE, Molineux ML, Hamid J, Snutch TP, Zamponi GW, Turner RW. (2006) Ca(V)3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons.
Eur J Neurosci, 24 (9): 2581-94.
[PMID:17100846]
22. Monteil A, Chemin J, Leuranguer V, Altier C, Mennessier G, Bourinet E, Lory P, Nargeot J. (2000) Specific properties of T-type calcium channels generated by the human alpha 1I subunit.
J Biol Chem, 275 (22): 16530-5.
[PMID:10749850]
23. Murbartián J, Arias JM, Perez-Reyes E. (2004) Functional impact of alternative splicing of human T-type Cav3.3 calcium channels.
J Neurophysiol, 92 (6): 3399-407.
[PMID:15254077]
24. Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, Parker D, Stea A, Snutch TP. (2002) Differential inhibition of T-type calcium channels by neuroleptics.
J Neurosci, 22 (2): 396-403.
[PMID:11784784]
25. Shcheglovitov AK, Boldyrev AI, Lyubanova OP, Shuba YM,. (2005) Peculiarities of selectivity of three subtypes of low-threshold T-type calcium channels.
Neurophysiology, 37 (4): 277-286.
26. Shcheglovitov AK, Boldyrev AI, Lyubanova OP, Shuba YM,. (2005) Peculiarities of selectivity of three subtypes of low-threshold T-type calcium channels.
Neurophysiology, 37 (4): 277-286.
27. Shcheglovitov AK, Boldyrev AI, Lyubanova OP, Shuba YM,. (2005) Peculiarities of selectivity of three subtypes of low-threshold T-type calcium channels.
Neurophysiology, 37 (4): 277-286.
28. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. (1999) Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels.
J Neurosci, 19 (6): 1895-911.
[PMID:10066243]
29. Tringham E, Powell KL, Cain SM, Kuplast K, Mezeyova J, Weerapura M, Eduljee C, Jiang X, Smith P, Morrison JL et al.. (2012) T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures.
Sci Transl Med, 4 (121): 121ra19.
[PMID:22344687]
30. Wallace SJ. (1986) Use of ethosuximide and valproate in the treatment of epilepsy.
Neurologic clinics, 4 (3): 601-16.
[PMID:3092003]
31. Xiang Z, Thompson AD, Brogan JT, Schulte ML, Melancon BJ, Mi D, Lewis LM, Zou B, Yang L, Morrison R et al.. (2011) The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.
ACS Chem Neurosci, 2 (12): 730-742.
[PMID:22368764]
32. Xie X, Van Deusen AL, Vitko I, Babu DA, Davies LA, Huynh N, Cheng H, Yang N, Barrett PQ, Perez-Reyes E. (2007) Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches.
Assay Drug Dev Technol, 5 (2): 191-203.
[PMID:17477828]